Dehner L
Mo Med. 2024; 121(4):262-268.
PMID: 39575077
PMC: 11578564.
Roy U, Sharma A, Sharma S, Dahal S, Kumari N, Desai S
Mol Cell Biol. 2024; 44(12):590-606.
PMID: 39511874
PMC: 11583620.
DOI: 10.1080/10985549.2024.2419661.
Mohammad T, Zolotovskaia M, Suntsova M, Buzdin A
Front Oncol. 2024; 14:1415801.
PMID: 38919532
PMC: 11196610.
DOI: 10.3389/fonc.2024.1415801.
Fischer J, Erkner E, Fitzel R, Radszuweit P, Keppeler H, Korkmaz F
Int J Mol Sci. 2023; 24(19).
PMID: 37833915
PMC: 10572120.
DOI: 10.3390/ijms241914466.
Powell S, Kulakova K, Kennedy S
Int J Mol Sci. 2023; 24(18).
PMID: 37762061
PMC: 10530759.
DOI: 10.3390/ijms241813755.
The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology.
Nejati-Koshki K, Roberts C, Babaei G, Rastegar M
Cancers (Basel). 2023; 15(10).
PMID: 37345019
PMC: 10216337.
DOI: 10.3390/cancers15102683.
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity.
Fitzel R, Secker-Grob K, Keppeler H, Korkmaz F, Schairer R, Erkner E
Neoplasia. 2023; 41:100902.
PMID: 37148657
PMC: 10192941.
DOI: 10.1016/j.neo.2023.100902.
Whole transcriptome sequencing reveals HOXD11-AGAP3, a novel fusion transcript in the Indian acute leukemia cohort.
Desai S, Ravindran F, Panchal A, Ojha N, Jadhav S, Choudhary B
Front Genet. 2023; 14:1100587.
PMID: 37113989
PMC: 10126405.
DOI: 10.3389/fgene.2023.1100587.
One Patient With 4 Different Primary Cancers: A Case Report.
Nguyen D, Nguyen L, Phan T, Bui Q
Clin Med Insights Case Rep. 2023; 16:11795476221150597.
PMID: 36726425
PMC: 9885030.
DOI: 10.1177/11795476221150597.
New Insights into the Identity of the DFNA58 Gene.
Nascimento L, Vieira-Silva G, Kitajima J, Batissoco A, Lezirovitz K
Genes (Basel). 2022; 13(12).
PMID: 36553541
PMC: 9777997.
DOI: 10.3390/genes13122274.
Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration.
Yin J, Fang K, Gao Y, Ou L, Yuan S, Xin C
Nat Commun. 2022; 13(1):7867.
PMID: 36550137
PMC: 9780342.
DOI: 10.1038/s41467-022-35640-4.
Nonamer dependent RAG cleavage at CpGs can explain mechanism of chromosomal translocations associated to lymphoid cancers.
Paranjape A, Desai S, Nishana M, Roy U, Nilavar N, Mondal A
PLoS Genet. 2022; 18(10):e1010421.
PMID: 36228010
PMC: 9595545.
DOI: 10.1371/journal.pgen.1010421.
Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.
Humtsoe J, Kim H, Jones L, Cevallos J, Boileau P, Kuo F
Cancers (Basel). 2022; 14(9).
PMID: 35565392
PMC: 9103462.
DOI: 10.3390/cancers14092263.
Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation.
Stasevich E, Uvarova A, Murashko M, Khabusheva E, Sheetikov S, Prassolov V
Int J Mol Sci. 2022; 23(9).
PMID: 35563017
PMC: 9103539.
DOI: 10.3390/ijms23094624.
The Fusion of and Arises from a -Splicing Event in Normal and Transformed Human Cells.
Dhungel B, Monteuuis G, Giardina C, Tabar M, Feng Y, Metierre C
Int J Mol Sci. 2021; 22(22).
PMID: 34830054
PMC: 8625150.
DOI: 10.3390/ijms222212178.
DNA Fingerprint Analysis of Raman Spectra Captures Global Genomic Alterations in Imatinib-Resistant Chronic Myeloid Leukemia: A Potential Single Assay for Screening Imatinib Resistance.
Mojidra R, Hole A, Iwasaki K, Noothalapati H, Yamamoto T, C M
Cells. 2021; 10(10).
PMID: 34685486
PMC: 8533852.
DOI: 10.3390/cells10102506.
Targeting chromosome trisomy for chromosome editing.
Abe T, Suzuki Y, Ikeya T, Hirota K
Sci Rep. 2021; 11(1):18054.
PMID: 34508128
PMC: 8433146.
DOI: 10.1038/s41598-021-97580-1.
Chromosomal Translocations in NK-Cell Lymphomas Originate from Inter-Chromosomal Contacts of Active rDNA Clusters Possessing Hot Spots of DSBs.
Tchurikov N, Uroshlev L, Klushevskaya E, Alembekov I, Lagarkova M, Kravatskaya G
Cancers (Basel). 2021; 13(15).
PMID: 34359791
PMC: 8345467.
DOI: 10.3390/cancers13153889.
Chromatin Mechanisms Driving Cancer.
Gryder B, Scacheri P, Ried T, Khan J
Cold Spring Harb Perspect Biol. 2021; 14(3).
PMID: 34187809
PMC: 8886982.
DOI: 10.1101/cshperspect.a040956.
Development of a Novel Class of Self-Assembling dsRNA Cancer Therapeutics: A Proof-of-Concept Investigation.
Asthana V, Stern B, Tang Y, Bugga P, Li A, Ferguson A
Mol Ther Oncolytics. 2020; 18:419-431.
PMID: 32913891
PMC: 7452102.
DOI: 10.1016/j.omto.2020.07.013.